Journal of Pediatric Urology
Volume 5, Issue 4 , Pages 254-264 , August 2009

Pediatric hemorrhagic cystitis

  • Daniel B. Decker

      Affiliations

    • Children's Medical Center at Dallas, University of Texas Southwestern Medical Center, Department of Urology, 5323 Harry Hines Boulevard, Dallas, TX 75390-9110, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 (336) 721 1487; fax: +1 (214) 648 8786.
    • ,
  • Jose A. Karam

      Affiliations

    • Children's Medical Center at Dallas, University of Texas Southwestern Medical Center, Department of Urology, 5323 Harry Hines Boulevard, Dallas, TX 75390-9110, USA
    • ,
  • Duncan T. Wilcox

      Affiliations

    • The Children's Hospital, University of Colorado at Denver, 13123 East 16th Avenue, B463 Aurora, CO 80045, USA

Received 6 October 2008 ,Accepted 13 February 2009.

References 

  1. Hale GA, Rochester RJ, Heslop HE, Krance RA, Gingrich JR, Benaim E, et al. Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant. 2003;9:698–705
  2. Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005;11:797–804
  3. Hassan Z, Remberger M, Svenberg P, Elbander M, Omazic B, Mattsson J, et al. Hemorrhagic cystitis: a retrospective single-center survey. Clin Transplant. 2007;21:659–667
  4. Vögeli TA, Peinemann F, Burdach S, Ackermann R. Urologic treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation. Eur Urol. 1999;36:252–257
  5. Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, et al. Mesna compared with CBI as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol. 1993;11(7):1306–1310
  6. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. J Urol. 1982;20(3):256–258
  7. Pode D, Perlberg S, Steiner D. Busulfan-induced hemorrhagic cystitis. J Urol. 1983;130:347
  8. Russell SJ, Vowels MR, Vale T. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant. 1994;13(5):533–539
  9. Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999;23(3):277–282
  10. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in HC complicating BMT. Blood. 2001;98:1971–1978
  11. Chakrabarti S, Osman H, Collingham K, Milligan DW. Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning. Bone Marrow Transplant. 2003;31:379–386
  12. Iwamoto S, Azuma E, Hori H, Hirayama M, Kobayashi M, Komada Y, et al. BKV-associated fatal renal failure following late-onset hemorrhagic cystitis in unrelated bone marrow transplantation. Pediatr Hematol Oncol. 2002;19:255–261
  13. Ambinder RF, Burns W, Forman M, Charache P, Arthur R, Beschorner W, et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med. 1986;146:1400–1401
  14. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1:1253–1257
  15. Shah KV. Polyomaviruses. In: Fields virology. 3rd ed.. Philadelphia: Lippincott-Raven; 1996;
  16. Reploeg MD, Storch GA, Clifford DB. BK virus: a clinical review. Clin Infect Dis. 2001;33:191–202
  17. Elidemir O, Chang IF, Schecter MG, Mallory GB. BK virus-associated hemorrhagic cystitis in a pediatric lung transplant recipient. Pediatr Transplant. 2007;11:807–810
  18. Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, et al. Polyomavirus associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79:1277–1286
  19. Pahari A, Rees L. BK virus-associated renal problems—clinical implications. Pediatr Nephrol. 2003;18:743–748
  20. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis is recipients of bone marrow transplants. N Engl J Med. 1986;24(315):230–234
  21. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol. 1995;13:1103–1109
  22. Cesaro S, Facchin C, Tridello G, Messina C, Calore E, Biasolo MA, et al. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:363–370
  23. Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D, et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood. 2005;106:1130–1132
  24. Giraud G, Bogdanovic G, Priftakis P, Remberger M, Svahn BM, Barkholt L, et al. The incidence of hemorrhagic cystitis and BK viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Hematol J. 2006;91:401–404
  25. Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Santis R, et al. Human polyomavirus BK load and HC in BMT patients. J Clin Virol. 1999;14:79–86
  26. Bogdanovic G, Priftakis P, Taemmeraes B, Gustafsson A, Flaegstad T, Winiarski J, et al. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children. Pediatr Transplant. 1998;2:288–293
  27. Cox PJ. Cyclophosphamide cystitis—identification of acrolein as the causative agent. Biochem Pharmacol. 1979;28:2045–2049
  28. Moriyama Y, Koike T, Shibata A. Hemorrhagic cystitis after conditioning for bone marrow transplantation and its prophylaxis. Jpn J Clin Oncol. 1984;14:531–536
  29. Phillips FS, Sternberg SS, Cronin AP, Vidal PM. Cyclophosphamide and urinary bladder toxicity. Cancer Res. 1961;21:1577–1589
  30. Seber A, Shu XO, Defor T, Sencer S, Ramsay N. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant. 1999;23:35–40
  31. Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT. The efficacy of mesna as an uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy. J Clin Oncol. 1987;5:799–803
  32. Hows JM, Mehta A, Ward L, Woods K, Perez R, Gordon MY, et al. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomized study. Br J Cancer. 1984;50:753–756
  33. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991;9:2016–2020
  34. Turkeri LN, Lum LG, Uberti JP, Abella E, Momin F, Karanes C, et al. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. J Urol. 1995;153:637–640
  35. Hadjibabaie M, Alimoghaddam K, Shamshiri AR, Iravani M, Bahar B, Mousavi A, et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol. 2008;26:43–46
  36. deVries CR, Freiha FS. Hemorrhagic cystitis: a review. J Urol. 1990;143:1–9
  37. Donahue LA, Frank IN. Intravesical formalin for hemorrhagic cystitis: analysis of therapy. J Urol. 1989;141:809–812
  38. Godec C, Gleich P. Intractable hematuria and formalin. J Urol. 1983;130:688–691
  39. Jerkins GR, Noe HN, Hill DE. An unusual complication of silver nitrate treatment of hemorrhagic cystitis: case report. J Urol. 1986;136:456–458
  40. Efros MD, Ahmed T, Coombe N, Choudhury MS. Urologic complications of high-dose chemotherapy and bone marrow transplantation. Urology. 1994;43:355–360
  41. Goel AK, Rao MS, Bhagwat AG, Vaidyanathan S, Goswami AK, Sen TK. Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol. 1985;133:956–957
  42. Gattegno B, Guillemenot F, Fiatte P, Cohen L, Becker A, Gluckman E, et al. Treatment of HC caused by cyclophosphamide using intravesical instillation of potassium alum. A propos of 5 cases. Ann Urol. 1990;24:190–192
  43. Murphy CP, Cox RL, Harden EA, Stevens DA, Heye MM, Herzig RH. Encephalopathy and seizures induced by intravesical alum irrigations. Bone Marrow Transplant. 1992;10:383–385
  44. Perazella M, Brown E. Acute aluminum toxicity and alum bladder irrigation in patients with renal failure. Am J Kidney Dis. 1993;21:44–46
  45. Kanwar VS, Jenkins JJ, Mandrell BN, Furman WL. Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis. Med Pediatr Oncol. 1996;27:64–67
  46. Ippoliti C, Przepiorka D, Mehra R, Neumann J, Wood J, Claxton D, et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 1995;46:811–815
  47. Levine L, Jarrard D. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol. 1993;149:719–723
  48. Trigg ME, O'Reilly J, Rumelhart S, Morgan D, Holida M, de Alarcon P. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol. 1990;143:92–94
  49. Pitts TO, Spero JA, Bontempo FA, Greenberg A. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid. Am J Kidney Dis. 1986;8:441–444
  50. Lakhani A, Raptis A, Frame D, Simpson D, Berkahn L, Mellon-Reppen S, et al. Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplant. 1999;24:1259–1260
  51. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrobial Agents Chemother. 1997;41:587–593
  52. De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev. 2003;16:569–596
  53. Bjorang O, Tveitan H, Midtvedt K, Broch LU, Scott H, Andresen PA. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant. 2002;17:2023–2025
  54. González-Fraile MI, Cañizo C, Caballero D, Hernández R, Vázquez L, López C, et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis. 2001;3:44–46
  55. Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR, et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant. 2000;26:347–350
  56. Ribaud P, Scieux C, Freymuth F, Morinet F, Gluckman E. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis. 1999;28:690–691
  57. Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant. 2007;39:783–787
  58. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol. 2006;81:535–537
  59. Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V, et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis. 2005;40:199–201
  60. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosan polysulfate sodium for therapy of interstitial cystitis. Urology. 1990;35:552–558
  61. Kalota SJ, Stein PC, Parsons CL. Prevention of acrolein-induced bladder injury by pentosanpolysulfate. J Urol. 1992;148:163–166
  62. Parsons CL. Successful management of radiation cystitis with sodium pentosanpolysulfate. J Urol. 1986;136:813–814
  63. Hampson SJ, Woodhouse CR. Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: experience with 14 patients. Eur Urol. 1994;25:40–42
  64. Toren PJ, Norman RW. Cyclophosphamide induced hemorrhagic cystitis successfully treated with pentosanpolysulphate. J Urol. 2005;173:103
  65. Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med. 1997;3:1209–1215
  66. Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol. 1997;38:46–54
  67. Heath JA, Mishra S, Mitchell S, Waters KD, Tiedemann K. Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation. Bone Marrow Transplant. 2006;37:523–526
  68. Ordemann R, Naumann R, Geissler G, Bornhauser M, Schuler U, Ehninger G. Encouraging results in the treatment of haemorrhagic cystitis with estrogen – report of 10 cases and review of the literature. Bone Marrow Transplant. 2000;25:981–985
  69. Liu YK, Harty JI, Steinbock GS, Holt HA, Goldstein DH, Amin M. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol. 1990;144:41–43
  70. Miller J, Burfield GD, Moretti KL. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol. 1994;15:1348–1350
  71. Lupulescu A. Estrogen use and cancer risk: a review. Exp Clin Endocrinol. 1993;101:204–214
  72. Miodosky M, Abdul-Hai A, Tsirigotis P, Or R, Bitan M, Resnick IB, et al. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant. 2006;38:507–511
  73. Focosi D, Kast RE. Hyaluronate and risperidone for hemorrhagic cystitis. Bone Marrow Transplant. 2007;39:57
  74. Ashrani AA, Gabriel DA, Gajewski JL, Jacobs DR, Weisdorf DJ, Key NS. Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy. Bone Marrow Transplant. 2006;38:825–828
  75. Ringdén O, Uzunel M, Sundberg B, Lönnies L, Nava S, Gustafsson J, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia. 2007;21:2271–2276
  76. Schoenrock GJ, Cianci P. Treatment of radiation cystitis with hyperbaric oxygen. Urology. 1986;27:271–272
  77. Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment of hemorrhagic cystitis. Lancet. 1995;346:803–805
  78. Corman JM, McClure D, Pritchett R, Kozlowski P, Hampson NB. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol. 2003;169:2200–2202
  79. Norkool DM, Hampson NB, Gibbons RP, Weissman RM. Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol. 1993;150:332–334
  80. Weiss JP, Mattei DM, Neville EC, Hanno PM. Primary treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen: 10-year experience. J Urol. 1994;151:1514–1517
  81. Ashamalla HL, Thom SR, Goldwein JW. Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children. The University of Pennsylvania experience. Cancer. 1996;77:2407–2412
  82. Furness PD, Palmer LS, Palmer JS, Capelli-Schellpfeffer M, Cheng EY. Hyperbaric oxygen therapy for pediatric hemorrhagic cystitis. J Urol. 1999;161:1596–1597
  83. Bratsas KS, Stephanides AA, Spyropoulos E, Zachariades BP, Androulakakis PA. Hyperbaric oxygen therapy for cyclophosphamide induced refractory hemorrhagic cystitis in a child. J Urol. 2004;172:679
  84. Al-Seraihi A, Ayas M. Hyperbaric oxygen should not be used in the management of hemorrhagic cystitis in patients with Fanconi anemia. Pediatr Blood Cancer. 2007;49:854–856
  85. Müller-Mattheis V, Jürgens H, Göbel U, Ackermann R. Human fibrin glue as a new therapeutic concept in cyclophosphamide-induced cystitis and macrohematuria. Klin Padiatr. 1988;200:274–278
  86. Ouwenga MK, Langston MD, Campbell SC. Use of fibrin sealant in recalcitrant hemorrhagic cystitis. J Urol. 2004;172:1348
  87. Purves JT, Graham ML, Ramakumar S. Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis. Urology. 2005;66:641–643
  88. Hong SY, Pyo SJ, Lee HB. Effect of serum urokinase on urine fibrinolytic activity. Nephron. 1990;55:287–291
  89. Sneiders A, Pryor JL. Percutaneous nephrostomy drainage in the treatment of severe hemorrhagic cystitis. J Urol. 1993;150:966–967
  90. Zagoria RJ, Hodge RG, Dyer RB, Routh WD. Percutaneous nephrostomy for treatment of intractable hemorrhagic cystitis. J Urol. 1993;149:1449–1451
  91. Gonzalez CM, Case JR, Nadler RB. Glutaraldehyde cross-linked collagen occlusion of the ureteral orifices with percutaneous nephrostomy: a minimally invasive option for treatment of refractory hemorrhagic cystitis. J Urol. 2001;166:977–978
  92. Gine E, Rovira M, Real I, Burrel M, Montana J, Carreras E, et al. Successful treatment of severe hemorrhagic cystitis after hematopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant. 2003;31:923–925
  93. Han Y, Wu D, Sun A, Xie Y, Xu J, Zhou J, et al. Selective embolization of the internal iliac arteries for the treatment of severe hemorrhagic cystitis following hematopoietic SCT. Bone Marrow Transplant. 2008;41:881–886
  94. Palandri F, Bonifazi F, Rossi C, Falcioni S, Arpinati M, Giannini MB, et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant. 2005;35:529–530
  95. Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR. Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2000;26:899–901
  96. Okaneya T, Kontani K, Komijama I, Takezaki T. Severe cyclophosphamide-induced hemorrhagic cystitis successfully treated by total cystectomy with ileal neobladder substitution: a case report. J Urol. 1993;150:1909–1910

PII: S1477-5131(09)00270-8

doi: 10.1016/j.jpurol.2009.02.199

Journal of Pediatric Urology
Volume 5, Issue 4 , Pages 254-264 , August 2009

Article Tools

* Image Usage & Resolution